What’s the Problem?
According to the FDA Recall Notice, this action affects 100-count bottles of 500 mg Metformin Hydrochloride Extended-Release Tablets, USP, NDC Number 60505-0260-1, manufactured by Toronto, Canada-based Apotex Inc.
This recall was issued after FDA testing revealed the presence of N-Nitrosodimethylamine (NDMA), a known environmental contaminant that has been linked to an increased risk for cancer and liver damage, in samples of the affected metformin. Apotex Inc. discontinued the sale of its metformin in Feb. 2019; however, FDA believes there is still a limited quantity in circulation.
Consumers who purchased any metformin that is included in this recall should contact Apotex to return the product. Anyone concerned about potential health complications from NDMA in metformin should consult their physician.
Do I Have an Apotex Metformin Recall Class Action Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Apotex Metformin Recall Class Action Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or a loved one has been injured by recalled metformin, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.